Business Context and Reporting Period
This Form 8-K filing by Moderna, Inc. (MRNA) reports the results of the 2020 Annual Meeting of Stockholders held on April 29, 2020. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance voting results rather than financial performance.
Material Changes and Voting Results
Stockholders approved all four proposals submitted at the Annual Meeting:
- Proposal 1 (Election of Directors): Stockholders elected Stephen Berenson, Sandra Horning, M.D., and Paul Sagan as Class II directors for a three-year term. Significant broker non-votes were recorded for all candidates.
- Proposal 2 (Auditor Ratification): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2020.
- Proposal 3 (Executive Compensation): Stockholders approved, on a non-binding advisory basis, the compensation of the named executive officers.
- Proposal 4 (Say-on-Pay Frequency): Stockholders voted to hold future advisory votes on executive compensation on an annual basis.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting outcomes.
Investor Verification Checklist
- Verify the specific vote counts for the election of directors, noting the high number of broker non-votes (43,282,606) which did not affect the outcome but indicate broker discretion.
- Confirm the ratification of Ernst & Young LLP as the auditor for the 2020 fiscal year.
- Note the shareholder preference for annual "say-on-pay" votes regarding executive compensation.
- Review the company's 10-K or 10-Q filings for actual financial performance data, as this 8-K contains no financial metrics.
